US Patent 10633411 Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

106334110

Date of Patent

April 28, 2020

Patent Application Number

166873560

Date Filed

November 18, 2019

Patent Citations

‌

US Patent 10336786 Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway

‌

US Patent 10508129 Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway

Patent Citations Received

‌

US Patent 11492368 Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway

‌

US Patent 10696710 Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway

Patent Primary Examiner

‌

Jezia Riley

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10633411 Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API